SCHEMBL4453154

SCHEMBL4453154

CC(CP(c1ccccc1)c1ccccc1)C(C)CP(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.37
TRPA1 O75762 2/20 0.35
TAAR1 Q96RJ0 8/20 0.34
SLC6A2 P23975 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
MAOA P21397 2/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CYP2A6 P11509 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
SLC18A2 Q05940 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28430470 0.87 CYP2D6 (0.50) CYP2D6TAAR1SLC6A2SIGMAR1MAOA
SCHEMBL5838621 0.85 TDP1 (0.39) TDP1CYP3A4CYP2D6TRPA1TAAR1
SCHEMBL301154 0.85 TDP1 (0.39) TDP1CYP3A4CYP2D6TAAR1SLC6A2
SCHEMBL10412405 0.83 TDP1 (0.38) TDP1CYP3A4CYP2D6TAAR1SLC6A2
Bromide SCHEMBL1582867 0.81 TDP1 (0.36) TDP1CYP3A4CYP2D6TAAR1SLC6A2
SCHEMBL13722624 0.81 MAOA (0.46) CYP2D6TAAR1SLC6A2SIGMAR1MAOA
Hydrochloric Acid SCHEMBL1582787 0.81 TDP1 (0.36) TDP1CYP3A4CYP2D6TAAR1SLC6A2
SCHEMBL3297250 0.81 LMNA (0.42) TDP1CYP3A4CYP2D6TRPA1ESR1
SCHEMBL14980410 0.80 CYP3A4 (0.36) CYP3A4
SCHEMBL6291622 0.79 TAAR1 (0.50) TRPA1TAAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156763-A1 Process for manufacturing a thermoplastic elastomeric material PIRELLI & C. S.P.A. (IT) 2009-06-18 US claimed
EP-1970360-B1 Method for producing alcohols TAKASAGO PERFUMERY CO LTD (JP) 2016-08-31 EP disclosed
US-7569735-B2 Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature TAKASAGO INTERNATIONAL (JP) 2009-08-04 US disclosed
US-20090156763-A1 Process for manufacturing a thermoplastic elastomeric material PIRELLI & C. S.P.A. (IT) 2009-06-18 US disclosed
US-20080228012-A1 Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature TAKASAGO INTERNATIONAL CORPORATION 2008-09-18 US disclosed
EP-1970360-A1 Method for producing alcohols Takasago International Corporation (JP) 2008-09-17 EP disclosed
US-6835850-B2 Reacting a conjugated diene with carbon monoxide and an alcohol to form an alkenoic ester by using a durable catalyst complex of palladium cations, a ligand of bridged phospha-cycloalkanes and source of anions; by-product inhibition DSW IP ASSETS B.V. (NL) 2004-12-28 US disclosed
US-20040039226-A1 Process for the carbonylation of a conjugated diene DSM IP ASSETS B.V. (NL) 2004-02-26 US disclosed
US-6268530-B1 SEPARATING LINEAR 5-FORMYLVALERIC ACID FROM MIXTURE OF 5- AND 3-AND/OR 4-BRANCHED FORMYLVALERIC ACIDS BY SEPARATING FRACTIONAL EXTRACTION WITH TWO IMMISCIBLE SOLVENTS DSM N.V. (NL) 2001-07-31 US disclosed
EP-0836588-B1 PROCESS TO PREPARE 5-FORMYLVALERIC ACID DSM NV (NL) 2000-05-17 EP disclosed
US-4818810-A USING POLYMERIZATION CATALYST OF REACTION PRODUCT OF GROUP EIGHT COMPOUND, LIGAND AND ACID SHELL OIL COMPANY (US) 1989-04-04 US disclosed
EP-0293999-A2 Process for the coproduction of anilines and oxamides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-12-07 EP disclosed
EP-0293053-A2 Process for the preparation of cyclic carboxylic anhydrides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-11-30 EP disclosed
EP-0181014-B1 PROCESS FOR THE PREPARATION OF POLYKETONES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-11-30 EP disclosed
EP-0284170-A1 Process for the preparation of a diester of adipic acid SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-09-28 EP disclosed
US-4731487-A Process for the preparation of aldehydes SHELL OIL COMPANY (US) 1988-03-15 US disclosed
EP-0250037-A2 Process for the preparation of urea derivatives and catalyst system SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-12-23 EP disclosed
EP-0227160-A2 Process for the carbonylation of ethylenically unsaturated compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-07-01 EP disclosed
EP-0220767-A1 Process for the preparation of aldehydes SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-05-06 EP disclosed
EP-0121965-A2 Process for the preparation of polyketones SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1984-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039226-A1 Process for the carbonylation of a conjugated diene ROS1, DOHH, NOXO1 TDP1 2645/4885CYP3A4 209/4885CYP2D6 185/4885
US-20080228012-A1 Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature LPXN, LIPE, MLX TDP1 3947/4885CYP3A4 1279/4885CYP2D6 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.